Hikma Pharmaceuticals has appointed Henriette Nielsen to the newly created role of Chief Transformation Officer.
In this role, Nielsen will be responsible for leading a number of initiatives across Hikma’s global operations to improve operational efficiency and ensure that Hikma achieves its strategic objectives.
She will join Hikma’s Executive Committee and will report directly to Siggi Olafsson, Hikma’s CEO. Her appointment was effective from 4 June 2018.
Siggi Olafsson, CEO at Hikma, said: “Henriette brings extensive experience in pharmaceutical operations and transformation projects and has a strong track record of formulating and executing global strategic initiatives and developing multi-functional work plans. She brings an entrepreneurial attitude that I am confident will fit well within the Hikma culture.”
Nielsen joins Hikma from Teva Pharmaceuticals US, where she was most recently Senior VP, Chief Transformation Officer, Global Marketing & Portfolio. Her previous experience includes founder of System Matters, a healthcare and impact investing consultancy, and General Counsel and EVP at Actavis Group. She also held senior roles at Alpharma, Netdoktor and Kromann Reumert.
